SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
SciClone Pharmaceuticals (Holdings) Ltd
Operating Income
SciClone Pharmaceuticals (Holdings) Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
|
Operating Income
¥1.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Operating Income
¥3.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Operating Income
¥3.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
22%
|
CAGR 10-Years
21%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Operating Income
¥3.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
10%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Operating Income
¥3.7B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Operating Income
¥787.7m
|
CAGR 3-Years
32%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
See Also
What is SciClone Pharmaceuticals (Holdings) Ltd's Operating Income?
Operating Income
1.2B
CNY
Based on the financial report for Dec 31, 2023, SciClone Pharmaceuticals (Holdings) Ltd's Operating Income amounts to 1.2B CNY.
What is SciClone Pharmaceuticals (Holdings) Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
18%
Over the last year, the Operating Income growth was 9%. The average annual Operating Income growth rates for SciClone Pharmaceuticals (Holdings) Ltd have been 14% over the past three years , 18% over the past five years .